| The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia | Blood | 2016 | 5K |
| Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade | Science | 2017 | 3.3K |
| Unique microRNA molecular profiles in lung cancer diagnosis and prognosis | Cancer Cell | 2006 | 2.6K |
| Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet | Blood | 2010 | 2.5K |
| Hematopoietic stem-cell transplantation | New England Journal of Medicine | 2006 | 1.6K |
| First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer | New England Journal of Medicine | 2017 | 1.5K |
| Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation | New England Journal of Medicine | 2017 | 1.1K |
| Medullary thyroid cancer: management guidelines of the American Thyroid Association | Thyroid | 2009 | 1K |
| MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis | JAMA - Journal of the American Medical Association | 2007 | 928 |
| Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth | Nature | 2012 | 873 |
| The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody | Blood | 2010 | 595 |
| microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer | Oncogene | 2011 | 523 |
| Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study | Journal of Clinical Oncology | 2000 | 501 |
| Side effects of adjuvant treatment of breast cancer | New England Journal of Medicine | 2001 | 488 |
| PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome | Human Molecular Genetics | 1999 | 483 |
| The genomic landscape of hypodiploid acute lymphoblastic leukemia | Nature Genetics | 2013 | 474 |
| Prostate Cancer, Version 1.2016 | Journal of the National Comprehensive Cancer Network: JNCCN | 2016 | 473 |
| Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia | Nature Genetics | 2009 | 465 |
| Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? | Blood | 2007 | 452 |
| Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial | JAMA - Journal of the American Medical Association | 2017 | 434 |
| Consensus statement on the terminology and classification of central neck dissection for thyroid cancer | Thyroid | 2009 | 433 |
| Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia | Blood | 2015 | 431 |
| Patient navigation: state of the art or is it science? | Cancer | 2008 | 401 |
| Consensus guidelines for the management and treatment of neuroendocrine tumors | Pancreas | 2013 | 399 |
| Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine | Proceedings of the National Academy of Sciences of the United States of America | 2010 | 399 |
